| 1 |
29563296 | New Threats from H7N9 Influenza Virus: Spread and Evolution of High- and Low-Pathogenicity Variants with High Genomic Diversity in Wave Five. | 2018 Jun 1 |
1 |
| 2 |
28067324 | The in vivo efficacy of neuraminidase inhibitors cannot be determined from the decay rates of influenza viral titers observed in treated patients. | 2017 Jan 9 |
1 |
| 3 |
28413608 | Evidence synthesis and decision modelling to support complex decisions: stockpiling neuraminidase inhibitors for pandemic influenza usage. | 2016 |
1 |
| 4 |
25673705 | Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium. | 2015 Apr |
5 |
| 5 |
24445826 | Sequential influenza B viral load and susceptibility in children treated with oseltamivir and zanamivir. | 2014 Jul |
3 |
| 6 |
24566185 | Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y. | 2014 May |
2 |
| 7 |
18835410 | Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses. | 2009 Jan |
1 |